The efficacy and safety of PD-1/PD-L1 inhibitors versus chemotherapy in patients with previously treated advanced non-small-cell lung cancer: A meta-analysis

BACKGROUND: Immune checkpoint inhibitor therapy for non-small cell lung cancer is widely used in clinical practice. However, there has not been a systematic statistical proof of the efficacy of PD-1 inhibitors in patients with advanced cancer. This meta-analysis aims to evaluate its efficacy and rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Lin-guang-jin, Zhou, Dan-ni, Wang, Ting, Ma, Jun-zhi, Sui, Hua, Deng, Wan-li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282132/
https://www.ncbi.nlm.nih.gov/pubmed/33761681
http://dx.doi.org/10.1097/MD.0000000000025145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282132/
https://www.ncbi.nlm.nih.gov/pubmed/33761681
http://dx.doi.org/10.1097/MD.0000000000025145

Ejemplares similares